CClinicalTrials.gg
RecruitingNCT04832698Updated Jun 2, 2026

Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator Training

An observational study in Malignant Vascular Neoplasm, sponsored by M.D. Anderson Cancer Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by M.D. Anderson Cancer Center · Observational

From the registry’s dates

  • Started Jul 2020; still recruiting 6 years 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
9
Ages
18 Years and older
Sex
All
01

Study summary

This study looks at the comfort of interventional and diagnostic imaging residents in performing simulated endovascular procedures after completing training on the Mentice endovascular simulator device. Implementation of a training curriculum with radiology residents interested in interventional radiology will help facilitate hands-on training in a low-risk environment and allow for safer future patient encounters.

Read the detailed description

PRIMARY OBJECTIVE:

I. To measure trainee comfort performing simulated endovascular procedures after completing training on the Mentice endovascular simulator device.

OUTLINE:

Participants complete a survey over 10 minutes before and after completing training and using the Mentice endovascular simulator device.

02

Conditions studied

  • Malignant Vascular Neoplasm
03

In context

Lead sponsor

M.D. Anderson Cancer Center is the lead sponsor of 2,999 studies on the registry; 581 are open to participants now.

Of its 599 completed or terminated interventional studies of FDA-regulated products, 402 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Current interventional and diagnostic radiology residents participating in the training curriculum on the Mentice Endovascular Simulator at MD Anderson Cancer Center.

Eligibility criteria

Inclusion Criteria:

- Current interventional and diagnostic radiology residents participating in the training curriculum on the Mentice Endovascular Simulator will be eligible to participate in the survey

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
9 participants (estimated)

Groups and cohorts

  • Observational (survey administration)

    Participants complete a survey over 10 minutes before and after completing training and using the Mentice endovascular simulator device.

    Other: Survey Administration

Interventions

  • OtherSurvey Administration

    Complete survey

06

What researchers measure

Primary outcomes

  1. Trainees' feelings about using simulation to help with procedural training

    Will measure how trainees feel about using simulation to help with procedural training, and how comfortable trainees feel performing various endovascular procedures after undergoing training on the Mentice simulator machine.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
  • M D Anderson Cancer Center
    Houston, Texas 77030, United States
    Recruiting
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04832698
Lead sponsor
M.D. Anderson Cancer Center
Collaborators
National Cancer Institute (NCI)
Responsible party
Sponsor
First posted
Apr 6, 2021
Start date
Jul 8, 2020
Primary completion
Apr 30, 2028 (estimated)
Completion
Apr 30, 2028 (estimated)
Last update
Jun 2, 2026

Study contacts

Joshua D Kuban
Contact
JDKuban@mdanderson.org
713-792-1846
Joshua D Kuban
principal investigator · M.D. Anderson Cancer Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion